Mechelen, Belgium; 14 April 2008 - Galapagos NV (Euronext: GLPG) announced today the appointment of Dr. Piet Wigerinck as Senior Vice President of Development. As a member of Galapagos' Executive Team, Dr. Wigerinck will oversee the development of Galapagos' drug candidates, including pre-clinical development, chemistry manufacturing & control (CM&C), regulatory aspects, and clinical development.
